World

The United States does not consider India’s vaccine to be effective, and those who take covacin or Sputnik dosage need to take other vaccines.

U.S. In, since March, about 400 colleges and universities have announced that it is mandatory for students to take the covid vaccine during the winter season. This vaccination should be from a vaccine approved by the WHO.

New Delhi.

The United States has asked people who have been vaccinated against Kovacin or Sputnik to take a second dose of the vaccine. U.S. In, students who received Biotech’s Kovasin in India and Russia’s Sputnik-V vaccine have been instructed to re-vaccinate. Kovasin is an Indian and Russian Sputnik-V vaccine. However, the use of these two vaccines has not yet been approved by the WHO, the World Health Organization.

As of March, about 400 U.S. colleges and universities have announced that it is mandatory for students to be vaccinated against covid to join the winter semester, according to a report published in the American newspaper The New York Times. This vaccination should be from a vaccine approved by the WHO.

Also read: – The third wave of Corona has started! In a single district of Maharashtra, 8,000 infected children have been found

The order has now become a source of trouble for Indian and Russian students enrolled in American institutions who have been given doses of Kovasin or Sputnik-V vaccine. In such a situation, students are deeply concerned about getting two different vaccines and its potential side effects.

Earlier, Bharat Biotech said it expects to get emergency use approval from the WHO from July to September for its vaccine against corona epidemic. The company said regulatory approvals for covacin could be obtained in more than 60 countries between July and September this year. The company also said it has received EU in 13 countries. This process is nearing completion in many more countries. Kovasin has also been recommended by most countries.

READ ALSO: – Learn what the central government has to do to unlock a city, what to do and what not to do

At the same time, the WHO says it wants to get a little more information for emergency use of the vaccine. If any document submitted for evaluation is eligible to be included in the list, it will be notified.

Source by [author_name]

semidedicated hosting
Back to top button